Accumulating evidence suggests that ASPM is a regulator of cell stemness, it enhances stem cell phenotype in prostate cancer cells by enhancing Wnt/β-catenin signaling, thereby promoting tumor aggressiveness (38). This evidence concerns the gene ASPM and prostate cancer.